Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psycho-social Impact of Anti-NMDAR Encephalitis

NCT05954468 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT05954468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05954468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psycho-social Impact of Anti-NMDAR Encephalitis
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
October 9, 2023
Completion date
September 4, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nmdar antibody-associated auto-immune encephalitis